Search research articles
Contact Us
Filters
Showing results (631-640 of 656) with videos related to
Page
of 66
Sort By:
Med (New York, N.Y.)
|
January 24, 2023
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors
Nicolas Gonzalo Nuñez, Fiamma Berner, Ekaterina Friebel, et al.
The Lancet. Oncology
|
June 28, 2015
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
Antoni Ribas, Igor Puzanov, Reinhard Dummer, et al.
Nature
|
November 26, 2010
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Cory M Johannessen, Jesse S Boehm, So Young Kim, et al.
Journal of the National Cancer Institute
|
March 14, 2019
Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers
Clio Dessinioti, Niki Dimou, Alan C Geller, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2021
Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis
Simone M Goldinger, Kristina Buder-Bakhaya, Serigne N Lo, et al.
Nature Communications
|
March 5, 2021
Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling
Ismael A Vergara, Christopher P Mintoff, Shahneen Sandhu, et al.
Science Immunology
|
February 2, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8<sup>+</sup> T-myeloid cell networks in melanoma
David Barras, Eleonora Ghisoni, Johanna Chiffelle, et al.
Nature Communications
|
April 4, 2019
Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5<sup>-/-</sup> mice
Yan Li, Roberto Tinoco, Lisa Elmén, et al.
Nature Communications
|
July 20, 2019
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
Felicity Newell, Yan Kong, James S Wilmott, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases
Mario Mandalà, Monica F Chen, Ryan J Sullivan, et al.
Page
of 66
Search research articles
Search
Showing results (631-640 of 656) with videos related to
Sort By:
Page
of 66
Med (New York, N.Y.)
|
January 24, 2023
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors
Nicolas Gonzalo Nuñez, Fiamma Berner, Ekaterina Friebel, et al.
The Lancet. Oncology
|
June 28, 2015
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
Antoni Ribas, Igor Puzanov, Reinhard Dummer, et al.
Nature
|
November 26, 2010
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Cory M Johannessen, Jesse S Boehm, So Young Kim, et al.
Journal of the National Cancer Institute
|
March 14, 2019
Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers
Clio Dessinioti, Niki Dimou, Alan C Geller, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2021
Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis
Simone M Goldinger, Kristina Buder-Bakhaya, Serigne N Lo, et al.
Nature Communications
|
March 5, 2021
Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling
Ismael A Vergara, Christopher P Mintoff, Shahneen Sandhu, et al.
Science Immunology
|
February 2, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8<sup>+</sup> T-myeloid cell networks in melanoma
David Barras, Eleonora Ghisoni, Johanna Chiffelle, et al.
Nature Communications
|
April 4, 2019
Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5<sup>-/-</sup> mice
Yan Li, Roberto Tinoco, Lisa Elmén, et al.
Nature Communications
|
July 20, 2019
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
Felicity Newell, Yan Kong, James S Wilmott, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases
Mario Mandalà, Monica F Chen, Ryan J Sullivan, et al.
Page
of 66